Signet Financial Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,445
Closed -$386K 230
2020
Q2
$386K Buy
9,445
+95
+1% +$2.78K 0.09% 172
2020
Q1
$298K Sell
9,350
-1,000
-10% -$16.8K 0.07% 198
2019
Q4
$219K Hold
10,350
0.04% 227
2019
Q3
$178K Hold
10,350
0.03% 227
2019
Q2
$158K Sell
10,350
-3,375
-25% -$50.8K 0.03% 228
2019
Q1
$205K Hold
13,725
0.04% 221
2018
Q4
$196K Hold
13,725
0.04% 219
2018
Q3
$286K Sell
13,725
-361
-3% -$8.55K 0.05% 200
2018
Q2
$333K Buy
14,086
+13,496
+2,287% +$271K 0.06% 185
2018
Q1
$9K Sell
590
-15,135
-96% -$247K ﹤0.01% 601
2017
Q4
$254K Buy
15,725
+600
+4% +$7.08K 0.05% 186
2017
Q3
$211K Hold
15,125
0.04% 182
2017
Q2
$134K Sell
15,125
-7,650
-34% -$53.7K 0.03% 182
2017
Q1
$147K Sell
22,775
-7,000
-24% -$35.5K 0.03% 185
2016
Q4
$109K Hold
29,775
0.03% 178
2016
Q3
$97K Sell
29,775
-6,500
-18% -$18.2K 0.02% 166
2016
Q2
$84K Sell
36,275
-3,000
-8% -$10K 0.02% 169
2016
Q1
$98K Hold
39,275
0.02% 178
2015
Q4
$121K Sell
39,275
-5,400
-12% -$15.1K 0.02% 195
2015
Q3
$77K Hold
44,675
0.02% 180
2015
Q2
$181K Buy
+44,675
New +$183K 0.04% 178

Other funds holding IMMU

Signet Financial Management's IMMU Position: Q3 2020 in Review

Signet Financial Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 9,445 shares — an estimated $386K sold.

Signet Financial Management first reported a position in IMMU in Q2 2015 and held it in 21 quarters. The position peaked at $386K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Signet Financial Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Signet Financial Management sold 9,445 Immunomedics Inc shares in Q3 2020, an estimated $386K.
  • Signet Financial Management first reported a position in Immunomedics Inc in Q2 2015 and held it in 21 quarters.
  • Signet Financial Management's Immunomedics Inc position peaked at $386K in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Signet Financial Management's 13F filing for Q3 2020, filed 5 Nov 2020.